Passage Bio Correlations
| PASG Stock | USD 6.51 0.19 2.84% |
The current 90-days correlation between Passage Bio and Leap Therapeutics is -0.11 (i.e., Good diversification). The correlation of Passage Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Passage Bio Correlation With Market
Very good diversification
The correlation between Passage Bio and DJI is -0.3 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Passage Stock
| 0.76 | RAC | Race Oncology | PairCorr |
| 0.78 | VERA | Vera Therapeutics | PairCorr |
| 0.78 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.73 | VNDA | Vanda Pharmaceuticals | PairCorr |
Moving against Passage Stock
| 0.5 | DRMA | Dermata Therapeutics | PairCorr |
| 0.33 | DVAX | Dynavax Technologies Buyout Trend | PairCorr |
| 0.67 | 300238 | Guanhao Biotech | PairCorr |
| 0.64 | VPRO | Viropro | PairCorr |
| 0.44 | VXRT | Vaxart Inc Earnings Call This Week | PairCorr |
| 0.32 | KTTAW | Pasithea Therapeutics | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Passage Stock performing well and Passage Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Passage Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ENTO | 7.90 | 2.46 | 0.28 | (0.45) | 5.72 | 18.03 | 79.65 | |||
| LPTX | 7.19 | 0.91 | 0.09 | 1.05 | 8.73 | 19.05 | 65.13 | |||
| ENLV | 2.90 | (0.47) | 0.00 | (0.35) | 0.00 | 5.94 | 45.42 | |||
| APLM | 8.56 | 2.53 | 0.15 | (0.79) | 8.50 | 31.11 | 96.36 | |||
| SONN | 9.10 | 0.83 | 0.14 | 0.25 | 7.69 | 22.31 | 69.59 | |||
| ALLR | 5.17 | 0.26 | 0.09 | 0.17 | 4.61 | 13.75 | 63.00 | |||
| KAPA | 5.17 | (0.22) | (0.01) | 0.01 | 6.64 | 10.43 | 36.13 | |||
| BOLD | 1.92 | 0.06 | 0.01 | 0.15 | 2.28 | 5.26 | 13.44 | |||
| CVKD | 3.26 | 0.12 | 0.04 | 0.17 | 3.75 | 7.06 | 22.36 | |||
| DRTS | 2.64 | 0.26 | 0.06 | 0.80 | 3.30 | 5.69 | 14.54 |
Passage Bio Corporate Management
| Sue Browne | Senior Development | Profile | |
| Simona King | CFO Sec | Profile | |
| JD Esq | General Secretary | Profile | |
| Gregory Fuest | Vice Marketing | Profile | |
| MSc MBA | Chief Officer | Profile | |
| Kathleen Borthwick | Principal Finance | Profile |